Loading the security overview…
Where the tokens are
Peers
10 of 14 have tokenized versionsFirst the companies classified under the same themes, most themes in common first; then the ones investors most often look at alongside PFE. A peer with a tokenized version links to its own page, where every issuer that wraps it is listed.
| Company | Shared themes | Market cap | P/E | P/S | EV/EBITDA | ROE | F-Score | Altman zone |
|---|---|---|---|---|---|---|---|---|
 PFEThis companyPfizer Inc. | — | $160.27B | 37.0 | 2.5 | 9.4 | 5.1% | 6/9 | safe |
 MRKTokenizedMerck & Co., Inc. | Infectious Disease & Vaccines | $354.8B | 111.8 | 5.3 | 29.3 | 7.6% | 5/9 | safe |
 GILDTokenizedGilead Sciences Inc | Infectious Disease & Vaccines | $182.89B | — | 6.0 | 63.8 | −27.4% | 8/9 | safe |
 GSKTokenizedGSK plc American Depositary Shares (Each representing two Ordinary Shares) | Infectious Disease & Vaccines | $101.06B | — | — | — | — | 8/9 | — |
 MRNATokenizedModerna, Inc. Common Stock | Infectious Disease & Vaccines | $75.43B | — | 33.9 | -24.1 | −46.6% | 2/9 | safe |
 BNTXTokenizedBioNTech SE American Depositary Share | Infectious Disease & Vaccines | $26.08B | — | — | — | — | — | — |
 SMMTTokenizedSummit Therapeutics Inc. Common Stock | Infectious Disease & Vaccines | $13.31B | — | — | -14.7 | −135.9% | 1/9 | safe |
 PCVXVaxcyte, Inc. Common Stock | Infectious Disease & Vaccines | $8.34B | — | — | -7.2 | −38.6% | 1/9 | safe |
 BCRXBioCryst Pharmaceuticals Inc | Infectious Disease & Vaccines | $2.07B | — | 2.2 | -8.8 | 84.7% | 7/9 | distress |
 VIRVir Biotechnology, Inc. Common Stock | Infectious Disease & Vaccines | $1.91B | — | 6.3 | -6.1 | −25.6% | 3/9 | safe |
 NVAXNovavax Inc | Infectious Disease & Vaccines | $1.75B | — | 4.2 | -15.7 | 129.9% | 5/9 | distress |
 JNJTokenizedJohnson & Johnson | compared by investors | $623.34B | 29.6 | 6.4 | 19.2 | 24.8% | 4/9 | safe |
 LLYTokenizedEli Lilly & Co. | compared by investors | $1.02T | 38.4 | 12.9 | 25.7 | 78.8% | 7/9 | safe |
 AZNTokenizedAstraZeneca PLC | compared by investors | $244.58B | 110.1 | 10.2 | 48.8 | 16.4% | 8/9 | safe |
 ABBVTokenizedABBVIE INC. | compared by investors | $459.33B | 73.0 | 7.1 | 17.8 | −106.0% | 9/9 | safe |
Figures describe Pfizer shares, not any token. From theme classifications, Massive's related companies and the latest ratios and scores. Ratios are trailing, each as of its own latest filing. Peers are for comparison, not a list of alternatives to buy.